Navigation Links
Ohr Pharmaceutical Appoints June S. Almenoff to Board of Directors
Date:5/22/2013

ely from those expressed in any forward-looking statements as a result of various factors and uncertainties, including the future success of our scientific studies, our ability to successfully develop products, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments, the financial resources available to us, and general economic conditions. Shareholders and prospective investors are cautioned that no assurance of the efficacy of pharmaceutical products can be claimed or assured until final testing, and no assurance or warranty can be made that the FDA or Health Canada will approve final testing or marketing of any pharmaceutical product. Ohr's most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q discuss some of the important risk factors that may affect our business, results of operations and financial condition. We disclaim any intent to revise or update publicly any forward-looking statements for any reason.

Contact:
Ohr Pharmaceutical Inc.
Investor Relations:
Tel: (877) 215-4813
Email: ir@ohrpharmaceutical.com


'/>"/>
SOURCE Ohr Pharmaceutical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. China Pharmaceutical Market Guidebook Series (4) 2013 Report
2. Valeant Pharmaceuticals Announces 2013 Annual Meeting Results
3. Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors
4. Research-based Pharmaceutical Industry Launches Do You Mind? Campaign to Fight Mental and Neurological Disorders
5. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
6. Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology
7. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
8. Aveo Pharmaceuticals, Inc. Sued by Investor
9. Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment
10. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
11. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... Research and Markets( http://www.researchandmarkets.com/research/58tdl6/pharmaceutical ... Grade Sodium Chloride Market by Applications, by Region - ... their offering. The pharmaceutical grade sodium chloride ... between 2014 and 2019 in terms of volume, and ... 2019. The report on Pharmaceutical grade sodium ...
(Date:7/6/2015)... , July 6, 2015 Celtaxsys, Inc., a ... including those with rare and orphan inflammatory disease indications, ... U.S. Food and Drug Administration (FDA) to begin a ... acebilustat (CTX-4430), in adult CF patients in the US. ... Europe will be filed soon after. ...
(Date:7/6/2015)... 6, 2015 Akcea Therapeutics, a wholly-owned ... ), announced today that the U.S. Food and ... volanesorsen (ISIS-APOCIII Rx ) for the treatment of ... a rare genetic disease characterized by extremely high ... Phase 2 study published in the NEJM in ...
Breaking Medicine Technology:Global Pharmaceutical Grade Sodium Chloride Market Report 2015 2Global Pharmaceutical Grade Sodium Chloride Market Report 2015 3Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6
... Oct. 7 Cornerstone Pharmaceuticals, Inc., a privately-held pharmaceutical ... A. Weinberg, Ph.D., a founding member of the Whitehead ... at MIT, has joined the company,s Scientific Advisory Board. ... first human oncogene (the ras oncogene that ...
... MAARSSEN, The Netherlands, Oct. 7 CPhI Worldwide ... largest annual meeting - returns to Madrid on 12 - 15 ... contract services and P-MEC equipment and technology events ... banner by the new, biotech-focused BioPh . The new ...
Cached Medicine Technology:Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board 2Cornerstone Pharmaceuticals Adds Acclaimed Cancer Research Pioneer Robert A. Weinberg, Ph.D. to Its Scientific Advisory Board 3CPhI 2009: Madrid Launch for BioPh Marks Pharma and Biotech Convergence 2CPhI 2009: Madrid Launch for BioPh Marks Pharma and Biotech Convergence 3
(Date:7/7/2015)... ... July 07, 2015 , ... Nationally-renowned attorneys in the realm ... the Invokana Ketoacidosis Lawsuit Center . The website provides information on Invokana ... persons wishing to learn more about Invokana lawsuits for kidney problems, ketoacidosis, heart ...
(Date:7/7/2015)... Chicago, Illinois (PRWEB) , ... July 07, 2015 ... ... in government program modernization, today announced they have been selected by the Department ... Validation (IV&V) services for its Medicaid Management Information System (MMIS) and Integrated Contact ...
(Date:7/6/2015)... ... July 06, 2015 , ... Respected southern California personal injury ... 2015, marking him as an attorney who has sharp legal skills as well as ... Distinction Award for 2015 from Martindale-Hubbell and a Top 10 Award from The National ...
(Date:7/6/2015)... , ... July 06, 2015 , ... On June 22, 2015, Fox News in a report titled “ Female Hair ... they turn age 35 a quarter of all women in the U.S. will suffer from ... is stigmatized and rarely discussed. One woman, a former beauty queen, who was interviewed for ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... The Asian-Pacific ... in 2014. It is expected to grow at a CAGR of over 3.2 percent ... , The growth is likely to be mainly spurred by an anticipated launch of ...
Breaking Medicine News(10 mins):Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 2Health News:National Attorneys Launch Invokana Ketoacidosis Lawsuit Center 3Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 2Health News:Fernando D. Vargas Awarded Top Honors in Personal Injury Law for 2015 from Two Respected Independent Organizations 3Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2
... that produces a mutant form of good cholesterol ... therapy// using the “normal” HDL gene, according to ... Cedars-Sinai Medical Center and reported in the Oct. ... College of Cardiology. ,Apolipoprotein A-I is a ...
... Steroid injections are apparently of no use in tennis elbow ... a new study in the BMJ says. // Australian researchers ... assured that their problem would be sorted out. ... and advised to gradually return to normal activities. The final ...
... prescription manager Medco Health solutions Inc. claims that parents of ... themselves. // The study examined the prescriptions of 107,000 children ... found that if one twin is taking ADHD medicine, it ... than non-twin siblings. ,Impulsiveness, hyperactivity and inattention are ...
... is far from declaring itself a polio-free state as another detection ... ,And this despite the fact that the victim was administered ... ,"A fresh polio case has come to light in Bhind ... along with 15 other districts in the state and 300,000 children ...
... a much better job of communicating critical elements of medication ... new UCLA study has found//. ,The study, slated for ... Internal Medicine, found that in too many instances, physicians did ... potential adverse side effects or even the names of drugs ...
... continuous demands for additional staff, the count of consultants ... 1% in three months//. The British Medical Association has ... vacancies in the Scotland Health Service. From the recent ... full time specialists in the NHS is inadequate to ...
Cached Medicine News:Health News:Gene Transfer Using Mutant Form of Good Cholesterol Cuts Vascular Plaque and Inflammation 2Health News:Gene Transfer Using Mutant Form of Good Cholesterol Cuts Vascular Plaque and Inflammation 3Health News:Steroids Ineffective In Tennis Elbow 2Health News:Physician Communication Spotty When Prescribing Medications 2
... cleanser will not leave your hands dry, ... With persistent Antimicrobial action, CHG Skin Cleanser ... gram-negative and gram-positive bacteria, fungi, and yeasts. ... second hand wash. The solution does not ...
IV Prep Antiseptic Wipes are effective and easy to apply. They are ideal for preparation of the skin prior to a ventipuncture or injection....
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
... Triad Plus Skin Protectant Swabsticks prepare ... dressing or bandage. When dry, they leave ... This provides a clean surface and a ... affect the adhesion of a dressing or ...
Medicine Products: